HETLIOZ (TASIMELTEON) CAPSULES Trademark
Trademark Overview
On Monday, April 1, 2019, a trademark application was filed for HETLIOZ (TASIMELTEON) CAPSULES with the United States Patent and Trademark Office. The USPTO has given the HETLIOZ (TASIMELTEON) CAPSULES trademark a serial number of 88366693. The federal status of this trademark filing is REGISTERED as of Tuesday, April 28, 2020. This trademark is owned by Vanda Pharmaceuticals Inc.. The HETLIOZ (TASIMELTEON) CAPSULES trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; and pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder
General Information
| Serial Number | 88366693 |
| Word Mark | HETLIOZ (TASIMELTEON) CAPSULES |
| Filing Date | Monday, April 1, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 28, 2020 |
| Registration Number | 6040230 |
| Registration Date | Tuesday, April 28, 2020 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 16, 2019 |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "TASIMELTEON CAPSULES" |
| Description of Mark | The mark consists of the word "HETLIOZ" on a first line, and "(TASIMELTEON) CAPSULES" on a second line, with an arc of eleven solid circles of increasing size connecting the first and second lines of text. |
| Goods and Services | Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; and pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 19, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, April 15, 2014 |
| First Use In Commerce Date | Tuesday, April 15, 2014 |
Trademark Owner History
| Party Name | Vanda Pharmaceuticals Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20037 |
| Party Name | Vanda Pharmaceuticals Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20037 |
| Party Name | Vanda Pharmaceuticals Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20037 |
Trademark Events
| Event Date | Event Description |
| Tuesday, April 28, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, March 25, 2020 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Tuesday, March 3, 2020 | NOTICE OF ALLOWANCE CANCELLED |
| Wednesday, March 25, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, March 3, 2020 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Tuesday, September 10, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 16, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 16, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 26, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 12, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 11, 2019 | ASSIGNED TO EXAMINER |
| Saturday, April 20, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, April 19, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, April 4, 2019 | NEW APPLICATION ENTERED IN TRAM |
